Univ.-Prof. Dr. Sebastian Friedrich Schoppmann

President Elect (2017-2019)
Generalsekretär

Leitender Oberarzt der Universitätsklinik f. Chirurgie
Stv. Leiter der Abteilung f. Allgemeinchirurgie
Leiter Upper-GI-Service 
Koordinator der Cancer Comprehensive Center GET-Unit
 
Medizinische Universität Wien, AKH Wien
Währinger Gürtel 18-20

Tel: 01-40400-56210,
Fax: 01-40400-56410
sebastian.schoppmann@meduniwien.ac.at


LEBENSLAUF (beruflich)

1994 Beginn des Medizinstudiums an der Universität Wien.
1997 Beginn der Tätigkeit als wissenschaftlicher Mitarbeiter am Institut für Ultrastrukturpathologie (Prof. Kerjaschki) mit Forschungsschwerpunkt lymphatische Metastasierung und Endothelzelldifferenzierung.
2000 Verleihung des Akademischen Grades „Doktor der gesamten Heilkunde“ mit Ablieferung der wissenschaftlichen Arbeit (Dissertation): “Lymphatic Microvessels in Invasive Breast Tumors – a Prognostic Factor?”
2000 Vertragsassistent am Institut für klinische Pathologie, Medizinische Universität Wien (Prof. Kerjaschki).
2000-2001 6 Monate extramurale Post-doc-Stelle am IMP- Research Institut of Molecular Pathology Vienna und dem Institut für Molekulare Pathologie (IMP) (Prof. Christofori). Forschungsschwerpunkt. Lymphangiogenses und lymphatische Endothelzelldifferenzierung bei der Angiogenese und Lymphangiogenese des Pankreas.
2001-2007 Universitätsassistent auf der Universitätklinik für Chirurgie (Prof. Mühlbacher), Abteilung für Allgemeinchirurgie (Prof Jakesz).
2006 klinisches Auswärtssemester am Landesklinikum St. Pölten (Prof. Salem)
2006 Verleihung der Venia docendi im Fach „Chirurgie“ der Medizinischen Universität Wien. Habilitationsthema: Lymphatische Metastasierungsmechanismen beim humanen Karzinomen und deren klinische Signifikanz.
01.03.2007 01.03.2007 Verleihung des Titels außerordentlicher Universitätsprofessor
14.12.2007 Facharzt für Chirurgie
01.10.2008 Consulent am Prince Court Medical Center, Kuala Lumpur, Malaysien (MUVI) und Etablierung einer Upper-GI-Unit.
seit 01.01.2009 Oberarzt and der Universitätsklinik für Chirurgie
seit 01.12.2009 Curriculumsdirektor European Society of Quality in Health (Vienna Office) ESQH
seit 2010 Leiter der Forschungsgruppe „Upper GI Research“ im chirurgischen Forschungslabor, MUW

Wissenschaftliche Preise:

  • Billroth-Preis der Ärztekammer für Wien 2003 für die Arbeit:
    S. F. Schoppmann, P. Birner, J. Stöckl, R. Kalt, R. Ullrich, E. Kriehuber, K. Nagy, K. Alitalo, Dontscho Kerjaschki: “ Tumor associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis ” Am J Pathol 2002 Sep;161(3):947-56.
  • Förderungspreis des Fonds der Stadt Wien für innovative interdisziplinäre Krebsforschung 2004
    S. F. Schoppmann, G. Bayer, K. Aumayr, S. Taucher, S. Geleff, M. Rudas, E. Kubista, H. Hausmaninger, H. Samonigg, M. Gnant, R. Jakesz, R. Horvat; Austrian Breast and Colorectal Cancer Study Group:” Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer” Ann Surg. 2004 Aug;240(2):306-12
  • ACO-ASSO-Preis 2007
    S.F. Schoppmann, A. Fenzl, S. Glueck, G. Bayer, S. Geleff, M. Gnant, R. Horvat, R. Jakesz, and P. Birner: “VEGF-C-expressing tumor associated macrophages in lymph node positive breast cancer: Imapct on lymphangiogenesis and survival.” Surgery 2006 Jun;139(6):839-46.
  • Billroth-Preis 2007
    Bachleitner-Hofmann T, Strohschneider M, Krieger P, Sachet M, Dubsky P, Hayden H, Schoppmann S.F, Pfragner R, Gnant M, Friedl J, Stift A: “Heat shock treatment of tumor lysate-pulsed DCs enhances their capacity to elicit antitumor T-cell responses against medullary thyroid carcinoma” J Clin Endocrinol Metab. 2006 Nov;91(11):4571-7.

Forschungsschwerpunkte:

  • Minimal Invasive onkologische Chirurgie
  • Minimal Invasive Chirurgie
  • Endoskopische Chirurgie
  • Angiogenese
  • Lymphangiogenses
  • Metastasierung
  • Translationelle Forschung
  • Minimal Invasive Techniken in der oberen Gastrointestinalchirurgie
  • Prediktive Faktoren in der Tumorbehandlung

Consulting Editor for:

  • Annals of Surgical Oncology, Journal of Leucocyte Biology, Acta Biologica Hungarica, British Journal of Cancer, British Journal of Surgery, Oncology, Deutsche Forschungsgemeinschaft (DFG), British Journal of Oncology, BMC Cancer, Cell and Molecular Life Science, World Journal of Surgical Oncology, Breast Care, European Journal of surgical Oncology, Journal for Cellular and Molecular Biology,
  • Consulting Editor for Journal of Leucocyte Biology
  • Associate Edfitor für European Journal of Surgical Oncology

Betreute Diplomanten und Dissertanten

SS2003 Dr. med. Julia Dienes (Dissertation)
WS2004/2005 Dr. med. Alexandra Fenzl (Dissertation)
WS2006/2007 c.m Gerd Jomrich (Diplomarbeit)
WS2006/2007 c.m Lisa Roberts (Diplomarbeit)

Mitgliedschaften bei medizinischen Gesellschaften

  • Österreichischen Gesellschaft für chirurgische Onkologie (ACO-ASSO)
  • Österreichische Gesellschaft für Chirurgie
  • Österreichische Gesellschaft für Senologie
  • American Society of Clinical Oncology (ASCO)
  • Austrian Breast and Colorectal Cancer Study Group (ABCSG)
  • European Society of Medical Oncology (ESMO)

Weitere Funktionen

  • Consulent des niederösterreichischen NÖ Gesundheits- und Sozialfonds
  • Curriculum Director for European Society for Quality in Health Care (Austrian Section)
  • Im Vorstand der Österreichischen Gesellschaft für chirurgische Onkologie

Kongressorganisation

  • Sekretär der 26. Jahrestagung der ACO-ASSO 8.-10. 10. 2009
  • Sekretär der 27. Jahrestagung der ACO-ASSO 7.-9.10 2010

Ernennungen

05.12.2006 Verleihung der Venia docendi für das Fach Chirurgie
01.03.2007 Verleihung des Titel Außerordendlicher Universitätsprofessor

aktuelle LEHRE 2010 (als selbstständig Lehrender, Auswahl):

  • 562.533 07W-ongoing SE
    Interdisziplinäre Fallbesprechung: Ösophagus- und Magenkarzinom (Onkoforum)
  • 562.605 07W-ongoing VO
    Molekulare Metastasierungsmechanismen
  • 562.953 07S SK
    SSM 3 Projektstudie (Wahlplflicht)
  • 901.641 VO
    Interdisziplinäres Brustkrebsmanagement
  • 901.651 VO
    Neoangiogenese bei humanen Tumoren: Pathogenese, klinische Relevanz, Therapiemöglichkeiten
  • 901.841 VO
    Angiogenese und Lymphangiogenese beim Mammakarzinom
  • 901.845 VO
    Moleculare Mechanismen beim Mammakarzinom
  • 901.846 SE
    Chirurgisches Management gastrointestinaler Stromatumoren
  • 901.847
    Entzündung und Tumor – klinische Relevanz
  • 902.133
    Chirurgische Therapiekonzepte

Wissenschaftliche Publikationen

2014

  1. Zacherl J, Roy-Shapira A, Bonavina L, Bapaye A, Kiesslich R, Schoppmann SF, Kessler WR, Selzer DJ, Broderick RC, Lehman GA, Horgan S. Surg Endosc. 2014 Aug 19. [Epub ahead of print] PMID: 25135443
  2. Kandioler D, Schoppmann SF, Zwrtek R, Kappel S, Wolf B, Mittlböck M, Kührer I, Hejna M, Pluschnig U, Ba-Ssalamah A, Wrba F, Zacherl J .J Thorac Cardiovasc Surg. 2014 Jul 22. pii: S0022-5223(14)00905-2. doi: 10.1016/j.jtcvs.2014.06.079. [Epub ahead of print] PMID: 25135238
  3. Birner P, Berghoff AS, Dinhof C, Pirker C, Capper D, Schoppmann SF, Petzelbauer P, von Deimling A, Berger W, Preusser M. Arch Dermatol Res. 2014 Jul 30. [Epub ahead of print] PMID: 25073704
  4. Schoppmann SF, Ricken G, Ilhan-Mutlu A, Nirtl N, Streubel B, Preusser M, Birner P. Cancer Invest. 2014 Aug;32(7):363-7. doi: 10.3109/07357907.2014.919304. Epub 2014 Jun 4. PMID: 24897389
  5. Sahora K, Schindl M, Kuehrer I, Eisenhut A, Werba G, Brostjan C, Telek B, Ba’ssalamah A, Stift J, Schoppmann SF, Gnant M. Anticancer Res. 2014 May;34(5):2377-84. PMID: 24778046
  6. Schwameis K, Schwameis M, Zörner B, Lenglinger J, Asari R, Riegler FM, Schoppmann SF. Anticancer Res. 2014 May;34(5):2341-8. PMID: 24778041
  7. Birner P, Pusch S, Christov C, Mihaylova S, Toumangelova-Uzeir K, Natchev S, Schoppmann SF, Tchorbanov A, Streubel B, Tuettenberg J, Guentchev M. Cancer. 2014 Aug 15;120(16):2440-7. doi: 10.1002/cncr.28732. Epub 2014 Apr 25. PMID: 24771584
  8. Schwameis K, F, Stift J, Schoppmann S, Schwameis M, Stift A. Oncol Lett 2014May;7(5):1613-1617. Epub 2014 Feb 27. PMID: 24765188
  9. Lenglinger J, Riegler MF, Schoppmann SF. Ann Surg. 2014 Apr 16. [Epub ahead of print] No abstract available. PMID: 24743612
  10. Lenglinger J, Riegler MF, Schoppmann SF. Ann Surg. 2014 Apr 16. [Epub ahead of print] No abstract available. PMID: 24743612
  11. Riegler M, Asari R, Cosentini EP, Wrba F, Schoppmann SF. Z Gastroenterol. 2014 Apr;52(4):367-73. doi: 10.1055/s-0034-1366188. Epub 2014 Apr 9. German. PMID: 24718942
  12. Mesteri I, Schoppmann SF, Preusser M, Birner P. Eur J Cancer. 2014 May;50(7):1354-60. doi: 10.1016/j.ejca.2014.01.022. Epub 2014 Feb 21. PMID: 24565853
  13. Riegler M, Asari R, Schoppmann SF. J Gastrointest Surg. 2014 Apr;18(4):882-3. doi: 10.1007/s11605-013-2436-6. Epub 2013 Dec 24. No abstract available. PMID: 24366369
  14. Koperek O, Aumayr K, Schindl M, Werba G, Soleiman A, Schoppmann S, Sahora K, Birner P. APMIS. 2014 Jun;122(6):476-81. doi: 10.1111/apm.12194. Epub 2013 Oct 29. PMID: 24164699
  15. Riegler M, Schwameis K, Asari R, Schoppmann SF. J Clin Gastroenterol. 2014 Feb;48(2):191. doi: 10.1097/MCG.0b013e3182a49ff4. No abstract available. PMID: 24045278
  16. Mesteri I, Bayer G, Meyer J, Capper D, Schoppmann SF, von Deimling A, Birner P. Mod Pathol. 2014 Jan;27(1):135-44. doi: 10.1038/modpathol.2013.126. Epub 2013 Jul 26. PMID: 23887306
  17. Aumayr K, Soleiman A, Sahora K, Schindl M, Werba G, Schoppmann SF, Birner P.Appl Immunohistochem Mol Morphol. 2014;22(2):146-52. doi: 10.1097/PAI.0b013e31828dc392. PMID: 23702645

2013

  1. Schoppmann SF, Langer FB, Prager G, Zacherl J. Dis Esophagus. 2013 Feb-Mar;26(2):154-8. doi: 10.1111/j.1442-2050.2012.01337.x. Epub 2012 Mar 12. PMID: 22409454
  2. Panhofer P, Springer C, Izay B, Grasl M, Burian M, Schoppmann SF, Rath T, Jakesz R, Zacherl J. Langenbecks Arch Surg. 2013 Feb;398(2):221-30. doi: 10.1007/s00423-012-0995-8. Epub 2012 Sep 2. PMID: 22941244
  3. Preusser M, Capper D, Berghoff AS, Horvat R, Wrba F, Schindl M, Schoppmann SF, von Deimling A, Birner P. Appl Immunohistochem Mol Morphol. 2013 Mar;21(2):159-64. doi: 10.1097/PAI.0b013e31825d7402. PMID: 22820660
  4. Schoppmann SF, Jesch B, Riegler MF, Maroske F, Schwameis K, Jomrich G, Birner P. Clin Exp Metastasis. 2013 Apr;30(4):441-6. doi: 10.1007/s10585-012-9549-2. Epub 2012 Nov 19. PMID: 23161183
  5. Schoppmann SF, Jesch B, Zacherl J, Riegler MF, Friedrich J, Birner P. Surgery. 2013 Apr;153(4):526-34. doi: 10.1016/j.surg.2012.10.007. Epub 2013 Jan 4. PMID: 23294880
  6. Preusser M, Berghoff AS, Capper D, von Deimling A, Maroske F, Brodowicz T, Hejna M, Birner P, Schoppmann SF. Appl Immunohistochem Mol Morphol. 2013 Oct;21(5):426-30. doi: 10.1097/PAI.0b013e31827ce693. PMID: 23343956
  7. Schoppmann SF, Asari R, Riegler M. Endoscopy. 2013;45(2):152. doi: 10.1055/s-0032-1325964. Epub 2013 Jan 30. No abstract available. PMID: 23364842
  8. Schoppmann SF, Beer A, Nirtl N, Ba-Ssalamah A, Brodowicz T, Streubel B, Birner P. Cancer Lett. 2013 Jul 10;335(1):26-30. doi: 10.1016/j.canlet.2013.01.044. Epub 2013 Jan 31. PMID: 23376254
  9. Asari R, Riegler M, Schoppmann SF. Mol Cytogenet. 2013 Mar 4;6(1):10. doi: 10.1186/1755-8166-6-10. No abstract available. PMID: 23452763
  10. Preusser M, Berghoff AS, Ilhan-Mutlu A, Magerle M, Dinhof C, Widhalm G, Dieckmann K, Marosi C, Wöhrer A, Hackl M, Zöchbauer-Müller S, von Deimling A, Schoppmann SF, Zielinski CC, Streubel B, Birner P. Lung Cancer. 2013 Jun;80(3):278-83. doi: 10.1016/j.lungcan.2013.01.019. Epub 2013 Feb 27. PMID: 23453647
  11. Pluschnig U, Schoppmann SF, Preusser M, Datler P, Asari R, Ba-Ssalamah A, Schwameis K, Birner P, Zacherl J, Hejna M. Anticancer Res. 2013 Mar;33(3):1035-9. PMID: 23482778
  12. Preusser M, Berghoff AS, Ilhan-Mutlu A, Dinhof C, Magerle M, Marosi C, Hejna M, Capper D, VON Deimling A, Schoppmann SF, Birner P. Anticancer Res. 2013 Mar;33(3):1065-71. PMID:23482783
  13. Schoppmann SF, Streubel B, Birner P. Eur J Cancer. 2013 May;49(8):1876-81. doi: 10.1016/j.ejca.2013.02.005. Epub 2013 Mar 13. PMID:23490651
  14. Bareck E, Ba-Ssalamah A, Brodowicz T, Eisterer W, Häfner M, Högenauer C, Kastner U, Kühr T, Längle F, Liegl-Atzwanger B, Schoppmann SF, Widmann G.Wrba F, Zacherl J, Ploner F; Austrian representatives of Medical and Surgical Oncology, Pathology, Radiology, Nuclear Medicine, Gastroenterology, and Laboratory Medicine.Wien Med Wochenschr. 2013 Mar;163(5-6):137-52. doi: 10.1007/s10354-013-0187-3. Epub 2013 Mar 19. PMID:23508516
  15. Schwameis K, Ba-Ssalamah A, Wrba F, Birner P, Prager G, Hejna M, Schmid R, Asari R, Zacherl J, Schoppmann SF. Anticancer Res. 2013 May;33(5):2085-91. PMID:23645759
  16. Schoppmann SF, Alidzanovic L, Schultheis A, Perkmann T, Brostjan C, Birner P.PLoS One. 2013 Jun 26;8(6):e66941. Print 2013. PMID:23840559
  17. Schoppmann S. Pflege Z. 2013 Jul;66(7):422-5. German. No abstract available. PMID:23866545
  18. Ilhan-Mutlu A, Preusser M, Schoppmann SF, Asari R, Ba-Ssalamah A, Schwameis K, Pluschnig U, Birner P, Püspök A, Zacherl J, Hejna M.Anticancer Res. 2013 Aug;33(8):3455-9. PMID:23898119
  19. Schoppmann SF, Vinatzer U, Popitsch N, Mittlböck M, Liebmann-Reindl S, Jomrich G, Streubel B, Birner P. Clin Cancer Res. 2013 Oct 1;19(19):5329-39. doi: 10.1158/1078-0432.CCR-12-3863. Epub 2013 Aug 13. PMID:23942094
  20. Schwameis K, Fochtmann A, Schwameis M, Asari R, Schur S, Köstler W, Birner P, Ba-Ssalamah A, Zacherl J, Wrba F, Brodowicz T, Schoppmann SF. Int J Surg. 2013;11(9):801-6. doi: 10.1016/j.ijsu.2013.08.016. Epub 2013 Aug 30. PMID:23999064
  21. Lenglinger J, See SF, Beller L, Cosentini EP, Asari R, Wrba F, Riegler M, Schoppmann SF. Wien Klin Wochenschr. 2013 Oct;125(19-20):577-90. doi: 10.1007/s00508-013-0418-z. Epub 2013 Sep 6. Review.PMID:24061694
  22. Schindler A, Mozzanica F, Alfonsi E, Ginocchio D, Rieder E, Lenglinger J, Schoppmann SF, Scharitzer M, Pokieser P, Kuribayashi S, Kawamura O, Kusano M, Zelenik K.Ann N Y Acad Sci. 2013 Oct;1300:250-60. doi: 10.1111/nyas.12251. Review.PMID:24117647
  23. Asari R, Riegler M, Schoppmann SF.J Am Coll Surg. 2013 Dec;217(6):1155-6. doi: 10.1016/j.jamcollsurg.2013.08.012. No abstract available. PMID:24246629
  24. Hochgraeber I, Riesner C, Schoppmann S. Dementia (London). 2013 Nov;12(6):751-68. doi: 10.1177/1471301212444300. Epub 2012 Apr 19.PMID:24337638
  25. Hejna M, Birner P, Preusser M, Thallinger CM, Worel N, Asari R, Dolak W, Schmid R, Schoppmann SF, Raderer M. Mol Clin Oncol. 2013 Nov;1(6):1079-1083. Epub 2013 Sep 12. PMID:24649296

2012

  1. Lenglinger J, Riegler M, Cosentini E, Asari R, Mesteri I, Wrba F, Schoppmann SF. Anticancer Res. 2012 Dec;32(12):5465-73. Review. PMID: 23225453
  2. Lenglinger J, See SF, Beller L, Cosentini E, Asari R, Wrba F, Riegler M, Schoppmann SF. Acta Chir Iugosl. 2012;59(3):15-26. Review. PMID: 23654002
  3. Schoppmann SF, Jomrich G, Schwameis K, Streubl B, Birner P. Amplification but not translocation of ALK is a frequent event in esophageal cancer European Journal of Cancer in press Nov 2012
  4. Schoppmann SF, Jesch B, Zacherl J, Riegler M, Friedrich J, Birner P. Lymphangiogenesis and lymphovascular invasion diminishes prognosis in esophageal cancer Surgery. 2012 Nov 20; PubMed PMID: 00396060
  5. Lenglinger J, Riegler M, Cosentini E, Asari R, Mesteri I, Wrba F, Schoppmann SF. Review on the Annual Cancer Risk of Barrett‘s Esophagus in Persons with Symptoms of Gastroesophageal Reflux Disease. Anticancer Research 32, PubMed PMID: 4738292383
  6. Schoppmann SF, Jesch B, Riegler MF, Maroske F, Schwameis K, Jomrich G, Birner P. Podoplanin expressing cancer associated fibroblasts are associated with unfavourable prognosis in adenocarcinoma of the esophagus. Clin Exp Metastasis. 2012 Nov 19; PubMed PMID:23161183.
  7. Pilat N, Schoppmann S, Stift J, Mazal P, Wekerle T, Berlakovich GA. No Evidence for Recipient-Derived Hepatocytes in Serial Biopsies of Sex-Mismatched Liver Transplants. Transplantation. 2012 Nov 15; 94 (9) :953-957. PubMed PMID:23034562.
  8. Schoppmann SF, Riegler MF. Radial esophageal acid exposure and the dilated distal esophagus. J Gastroenterol. 2012 Nov; 47 (11) :1275-6. PubMed PMID:22763417.
  9. Panhofer P, Springer C, Izay B, Grasl M, Burian M, Schoppmann SF, Rath T, Jakesz R, Zacherl J. Influence of resection extent on morbidity in surgery for squamous cell cancer at the pharyngoesophageal junction. Langenbecks Arch Surg. 2012 Sep 2; PubMed PMID:22941244.
  10. Lenglinger J, Riegler M, Schoppmann S. Letter: cancer risk among persons with columnar-lined oesophagus. Aliment Pharmacol Ther. 2012 Sep; 36 (6) :599; author reply 600. PubMed PMID:22913846.
  11. Schoppmann SF, Jesch B, Friedrich J, Jomrich G, Maroske F, Birner P. Phosphorylation of signal transducer and activator of transcription 3 (STAT3) correlates with Her-2 status, carbonic anhydrase 9 expression and prognosis in esophageal cancer. Clin Exp Metastasis. 2012 Aug; 29 (6) :615-24. PubMed PMID:22484976.
  12. Birner P, Jesch B, Schultheis A, Schoppmann SF. RAF-kinase inhibitor protein (RKIP) downregulation in esophageal cancer and its metastases. Clin Exp Metastasis. 2012 Aug; 29 (6) :551-9. PubMed PMID:22460832.
  13. Preusser M, Capper D, Berghoff AS, Horvat R, Wrba F, Schindl M, Schoppmann SF, von Deimling A, Birner P. Expression of BRAF V600E Mutant Protein in Epithelial Ovarian Tumors. Appl Immunohistochem Mol Morphol. 2012 Jul 19; PubMed PMID:22820660.
  14. Schoppmann SF, Berghoff AS, Jesch B, Zacherl J, Nirtl N, Jomrich G, Maroske F, Streubel B, Mesteri I, Birner P. Expression of podoplanin is a rare event in sporadic gastrointestinal stromal tumors and does not influence prognosis. Future Oncol. 2012 Jul; 8 (7) :859-66. PubMed PMID:22830405.
  15. Schoppmann SF, Berghoff A, Dinhof C, Jakesz R, Gnant M, Dubsky P, Jesch B, Heinzl H, Birner P. Podoplanin-expressing cancer-associated fibroblasts are associated with poor prognosis in invasive breast cancer. Breast Cancer Res Treat. 2012 Jul; 134 (1) :237-44. PubMed PMID:22350732.
  16. Birner P, Schoppmann A, Schindl M, Dinhof C, Jesch B, Berghoff AS, Schoppmann SF. Human homologue for Caenorhabditis elegans CUL-4 protein overexpression is associated with malignant potential of epithelial ovarian tumours and poor outcome in carcinoma. J Clin Pathol. 2012 Jun; 65 (6) :507-11. PubMed PMID:22447918.
  17. Maresch J, Schoppmann SF, Thallinger CM, Zielinski CC, Hejna M. Her-2/neu gene amplification and over-expression in stomach and esophageal adenocarcinoma: from pathology to treatment. Crit Rev Oncol Hematol. 2012 Jun; 82 (3) :310-22. PubMed PMID:21783379.
  18. Birner P, Beer A, Vinatzer U, Stary S, Höftberger R, Nirtl N, Wrba F, Streubel B, Schoppmann SF. MAPKAP kinase 2 overexpression influences prognosis in gastrointestinal stromal tumors and associates with copy number variations on chromosome 1 and expression of p38 MAP kinase and ETV1. Clin Cancer Res. 2012 Apr 1; 18 (7) :1879-87. PubMed PMID:22351694.
  19. Schoppmann SF, Langer FB, Prager G, Zacherl J. Outcome and complications of long-term self-expanding esophageal stenting. Dis Esophagus. 2012 Mar 12; PubMed PMID:22409454.
  20. Lenglinger J, Riegler M, Schoppmann SF. Gastroesophageal reflux disease and metabolic syndrome. Intern Med. 2012; 51 (20) :2993. PubMed PMID:23064587.

2011

  1. Schoppmann A, Tamandl D, Herberger B, Längle F, Birner P, Geleff S, Grünberger T, Schoppmann SF. Comparison of lymphangiogenesis between primary colorectal cancer and corresponding liver metastases. Anticancer Res. 2011 Dec; 31 (12) :4605-11. PubMed PMID:22199337.
  2. Ba-Ssalamah A, Matzek W, Baroud S, Bastati N, Zacherl J, Schoppmann SF, Hejna M, Wrba F, Weber M, Herold CJ, Gore RM. Accuracy of hydro-multidetector row CT in the local T staging of oesophageal cancer compared to postoperative histopathological results. Eur Radiol. 2011 Nov; 21 (11) :2326-35. PubMed PMID:21710266.
  3. Pertl L, Zacherl J, Mancusi G, Gächter JN, Asari R, Schoppmann S, Bigenzahn W, Schneider-Stickler B. High risk of unilateral recurrent laryngeal nerve paralysis after esophagectomy using cervical anastomosis. Eur Arch Otorhinolaryngol. 2011 Nov; 268 (11) :1605-10. PubMed PMID:21706158.
  4. Birner P, Jesch B, Friedrich J, Riegler M, Zacherl J, Hejna M, Wrba F, Schultheis A, Schoppmann SF. Carbonic anhydrase IX overexpression is associated with diminished prognosis in esophageal cancer and correlates with Her-2 expression. Ann Surg Oncol. 2011 Nov; 18 (12) :3330-7. PubMed PMID:21519917.
  5. Starlinger P, Brugger P, Reiter C, Schauer D, Sommerfeldt S, Tamandl D, Kuehrer I, Schoppmann SF, Gnant M, Brostjan C. Discrimination between circulating endothelial cells and blood cell populations with overlapping phenotype reveals distinct regulation and predictive potential in cancer therapy. Neoplasia. 2011 Oct; 13 (10) :980-90. PubMed PMID:22028623; PubMed Central PMCID: PMC3201574.
  6. Schoppmann SF, Jesch B, Zacherl J, Wrba F, Hejna M, Maresch J, Langer FB, Riegler MF, Pluschnig U, Birner P. HER-2 status in primary oesophageal cancer, lymph nodes and distant metastases. Br J Surg. 2011 Oct; 98 (10) :1408-13. PubMed PMID:21618213.
  7. Bojic M, Pluschnig U, Zacherl J, Thallinger CM, Ba-Ssalamah A, Maresch J, Datler P, Schoppmann SF, Hejna M. Docetaxel, cisplatin and 5-fluorouracil plus granulocyte colony-stimulating factor prophylaxis in patients with metastatic adenocarcinoma of the stomach and gastroesophageal junction: experience at the Medical University of Vienna. Anticancer Res. 2011 Jun; 31 (6) :2379-82. PubMed PMID:21737668.
  8. Starlinger P, Brugger P, Schauer D, Sommerfeldt S, Tamandl D, Kuehrer I, Schoppmann SF, Gnant M, Brostjan C. Myelosuppression of thrombocytes and monocytes is associated with a lack of synergy between chemotherapy and anti-VEGF treatment. Neoplasia. 2011 May; 13 (5) :419-27. PubMed PMID:21532882; PubMed Central PMCID: PMC3084618.
  9. Schlarmann JG, Metzing S, Schoppmann S, Schnepp W. Germany’s First Young Carers Project’s Impact on the Children: Relieving the Entire Family A Qualitative Evaluation. Open Nurs J. 2011; 5:86-94. PubMed PMID:22135716; PubMed Central PMCID: PMC3227871.
  10. Starlinger P, Alidzanovic L, Schauer D, Brugger P, Sommerfeldt S, Kuehrer I, Schoppmann SF, Gnant M, Brostjan C. Platelet-stored angiogenesis factors: clinical monitoring is prone to artifacts. Dis Markers. 2011; 31 (2) :55-65. PubMed PMID:21896999.

2010

  1. Schoppmann SF, Jesch B, Friedrich J, Wrba F, Schultheis A, Pluschnig U, Maresch J, Zacherl J, Hejna M, Birner P. Expression of Her-2 in carcinomas of the esophagus. Am J Surg Pathol. 2010 Dec; 34 (12) :1868-73. PubMed PMID:21107094.
  2. Schoppmann SF, Prager G, Langer FB, Riegler FM, Kabon B, Fleischmann E, Zacherl J. Open versus minimally invasive esophagectomy: a single-center case controlled study. Surg Endosc. 2010 Dec; 24 (12) :3044-53. PubMed PMID:20464423.
  3. Starlinger P, Moll HP, Assinger A, Nemeth C, Hoetzenecker K, Gruenberger B, Gruenberger T, Kuehrer I, Schoppmann SF, Gnant M, Brostjan C. Thrombospondin-1: a unique marker to identify in vitro platelet activation when monitoring in vivo processes. J Thromb Haemost. 2010 Aug; 8 (8) :1809-19. PubMed PMID:20492458.
  4. Langer FB, Bohdjalian A, Shakeri-Leidenmühler S, Schoppmann SF, Zacherl J, Prager G. Conversion from sleeve gastrectomy to Roux-en-Y gastric bypass–indications and outcome. Obes Surg. 2010 Jul; 20 (7) :835-40. PubMed PMID:20393810.
  5. Langer FB, Shakeri-Leidenmühler S, Bohdjalian A, Schoppmann S, Zacherl J, Felberbauer FX, Vila G, Prager G. Strategies for weight regain after sleeve gastrectomy. Surg Laparosc Endosc Percutan Tech. 2010 Jun; 20 (3) :159-61. PubMed PMID:20551813.
  6. Schoppmann SF, Tamandl D, Roberts L, Jomrich G, Schoppmann A, Zwrtek R, Dubsky P, Gnant M, Jakesz R, Birner P. HER2/neu expression correlates with vascular endothelial growth factor-C and lymphangiogenesis in lymph node-positive breast cancer. Ann Oncol. 2010 May; 21 (5) :955-60. PubMed PMID:19940005.
  7. Langer FB, Schoppmann SF, Prager G, Riegler FM, Zacherl J. Solving the problem of difficult stent removal due to tissue ingrowth in partially uncovered esophageal self-expanding metal stents. Ann Thorac Surg. 2010 May; 89 (5) :1691-2. PubMed PMID:20417822.
  8. Langer FB, Schoppmann SF, Prager G, Tomaselli F, Pluschnig U, Hejna M, Schmid R, Zacherl J. Temporary placement of self-expanding oesophageal stents as bridging for neo-adjuvant therapy. Ann Surg Oncol. 2010 Feb; 17 (2) :470-5. PubMed PMID:19859771.

2009

  1. Schoppmann SF, Prager G, Langer F, Riegler M, Fleischman E, Zacherl J. Fifty-five minimally invasive Esophagectomies: a single centre experience. Anticancer Res. 2009 Jul; 29 (7) :2719-25. PubMed PMID:19596952.
  2. Silberhumer GR, Hufschmid M, Wrba F, Gyoeri G, Schoppmann S, Tribl B, Wenzl E, Prager G, Laengle F, Zacherl J. Surgery for gastrointestinal stromal tumors of the stomach. J Gastrointest Surg. 2009 Jul; 13 (7) :1213-9. PubMed PMID:19357931.
  3. Gnant M, Dubsky P, Fitzal F, Blaha P, Schoppmann S, Steger G, Marth C, Samonigg H, Hüttner K, Fohler H, Ruecklinger E, Jakesz R, Greil R, Austrian Breast and Colorectal Cancer Study Group. Maintaining bone density in patients undergoing treatment for breast cancer: is there an adjuvant benefit?. Clin Breast Cancer. 2009 Jun; 9 Suppl 1:S18-27. PubMed PMID:19561003.
  4. Gnant M, Mlineritsch B, Schippinger W, Luschin-Ebengreuth G, Pöstlberger S, Menzel C, Jakesz R, Seifert M, Hubalek M, Bjelic-Radisic V, Samonigg H, Tausch C, Eidtmann H, Steger G, Kwasny W, Dubsky P, Fridrik M, Fitzal F, Stierer M, Rücklinger E, Greil R, ABCSG-12 Trial Investigators, Marth C. Endocrine therapy plus zoledronic acid in premenopausal breast cancer. N Engl J Med. 2009 Feb 12; 360 (7) :679-91. PubMed PMID:19213681.
  5. Blaha P, Exner R, Borgo AD, Bigenzahn S, Panhofer P, Riedl O, Schoppmann S, Bachleitner-Hofmann T, Sporn E, Pluschnig U, Fitzal F, Steger G, Jakesz R, Dubsky P, Gnant M. Is Endocrine Therapy Really Pleasant? Considerations about the Long-Term Use of Antihormonal Therapy and Its Benefit/Side Effect Ratio. Breast Care (Basel). 2009; 4 (3) :155-161. PubMed PMID:21160541; PubMed Central PMCID: PMC2931002.
  6. Silberhumer GR, Györi G, Burghuber C, Neumayer C, Riegler M, Jakesz R, Prager G, Schoppmann SF, Zacherl J. The value of protecting the longitudinal staple line with invaginating sutures during esophageal reconstruction by gastric tube pull-up. Dig Surg. 2009; 26 (4) :337-41. PubMed PMID:19729925.

2008

  1. Mlineritsch B, Tausch C, Singer C, Luschin-Ebengreuth G, Jakesz R, Ploner F, Stierer M, Melbinger E, Menzel C, Urbania A, Fridrik M, Steger G, Wohlmuth P, Gnant M, Greil R, Austrian Breast, Colorectal Cancer Study Group (ABCSG). Exemestane as primary systemic treatment for hormone receptor positive post-menopausal breast cancer patients: a phase II trial of the Austrian Breast and Colorectal Cancer Study Group (ABCSG-17). Breast Cancer Res Treat. 2008 Nov; 112 (1) :203-13. PubMed PMID:18158620.
  2. Gnant M, Mlineritsch B, Luschin-Ebengreuth G, Kainberger F, Kässmann H, Piswanger-Sölkner JC, Seifert M, Ploner F, Menzel C, Dubsky P, Fitzal F, Bjelic-Radisic V, Steger G, Greil R, Marth C, Kubista E, Samonigg H, Wohlmuth P, Mittlböck M, Jakesz R, Austrian Breast and Colorectal Cancer Study Group (ABCSG). Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy. Lancet Oncol. 2008 Sep; 9 (9) :840-9. PubMed PMID:18718815.
  3. Tamandl D, Herberger B, Gruenberger B, Schoppmann SF, Puhalla H, Schindl M, Schima W, Jakesz R, Gruenberger T. Adequate preoperative staging rarely leads to a change of intraoperative strategy in patients undergoing surgery for colorectal cancer liver metastases. Surgery. 2008 May; 143 (5) :648-57. PubMed PMID:18436013.

2007

  1. Schoppmann S, Schröck R, Schnepp W, Büscher A. ‚Then I just showed her my arms ‚ Bodily sensations in moments of alienation related to self-injurious behaviour A hermeneutic phenomenological study. J Psychiatr Ment Health Nurs. 2007 Sep; 14 (6) :587-97. PubMed PMID:17718732.
  2. Schindl M, Gnant M, Schoppmann SF, Horvat R, Birner P. Overexpression of the human homologue for Caenorhabditis elegans cul-4 gene is associated with poor outcome in node-negative breast cancer. Anticancer Res. 2007 Mar-Apr; 27 (2) :949-52. PubMed PMID:17465225.
  3. Tamandl D, Gruenberger B, Herberger B, Schoppmann S, Bodingbauer M, Schindl M, Puhalla H, Fleischmann E, Schima W, Jakesz R, Laengle F, Gruenberger T. Selective resection of colorectal liver metastases. Eur J Surg Oncol. 2007 Mar; 33 (2) :174-82. PubMed PMID:17046194.

2006

  1. Bachleitner-Hofmann T, Strohschneider M, Krieger P, Sachet M, Dubsky P, Hayden H, Schoppmann SF, Pfragner R, Gnant M, Friedl J, Stift A. Heat shock treatment of tumor lysate-pulsed dendritic cells enhances their capacity to elicit antitumor T cell responses against medullary thyroid carcinoma. J Clin Endocrinol Metab. 2006 Nov; 91 (11) :4571-7. PubMed PMID:16954161.
  2. Schoppmann SF, Fenzl A, Schindl M, Bachleitner-Hofmann T, Nagy K, Gnant M, Horvat R, Jakesz R, Birner P. Hypoxia inducible factor-1alpha correlates with VEGF-C expression and lymphangiogenesis in breast cancer. Breast Cancer Res Treat. 2006 Sep; 99 (2) :135-41. PubMed PMID:16555123.
  3. Schoppmann SF, Fenzl A, Nagy K, Unger S, Bayer G, Geleff S, Gnant M, Horvat R, Jakesz R, Birner P. VEGF-C expressing tumor-associated macrophages in lymph node positive breast cancer: impact on lymphangiogenesis and survival. Surgery. 2006 Jun; 139 (6) :839-46. PubMed PMID:16782443.

2005

  1. Schoppmann SF. Lymphangiogenesis, inflammation and metastasis. Anticancer Res. 2005 Nov-Dec; 25 (6C) :4503-11. PubMed PMID:16334134.

2004

  1. Schoppmann SF, Bayer G, Aumayr K, Taucher S, Geleff S, Rudas M, Kubista E, Hausmaninger H, Samonigg H, Gnant M, Jakesz R, Horvat R, Austrian Breast and Colorectal Cancer Study Group. Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer. Ann Surg. 2004 Aug; 240 (2) :306-12. PubMed PMID:15273556; PubMed Central PMCID: PMC1356408.
  2. Schoppmann SF, Soleiman A, Kalt R, Okubo Y, Benisch C, Nagavarapu U, Herron GS, Geleff S. Telomerase-immortalized lymphatic and blood vessel endothelial cells are functionally stable and retain their lineage specificity. Microcirculation. 2004 Apr-May; 11 (3) :261-9. PubMed PMID:15280080.
  3. Valencak J, Heere-Ress E, Kopp T, Schoppmann SF, Kittler H, Pehamberger H. Selective immunohistochemical staining shows significant prognostic influence of lymphatic and blood vessels in patients with malignant melanoma. Eur J Cancer. 2004 Feb; 40 (3) :358-64. PubMed PMID:14746853.

2003

  1. Schoppmann SF, Schindl M, Bayer G, Aumayr K, Dienes J, Horvat R, Rudas M, Gnant M, Jakesz R, Birner P. Overexpression of Id-1 is associated with poor clinical outcome in node negative breast cancer. Int J Cancer. 2003 May 10; 104 (6) :677-82. PubMed PMID:12640673.
  2. Geleff S, Schoppmann SF, Oberhuber G. Increase in podoplanin-expressing intestinal lymphatic vessels in inflammatory bowel disease. Virchows Arch. 2003 Mar; 442 (3) :231-7. PubMed PMID:12647212.
  3. Schindl M, Schoppmann SF, Ströbel T, Heinzl H, Leisser C, Horvat R, Birner P. Level of Id-1 protein expression correlates with poor differentiation, enhanced malignant potential, and more aggressive clinical behavior of epithelial ovarian tumors. Clin Cancer Res. 2003 Feb; 9 (2) :779-85. PubMed PMID:12576450.

2002

  1. Schoppmann SF, Birner P, Stöckl J, Kalt R, Ullrich R, Caucig C, Kriehuber E, Nagy K, Alitalo K, Kerjaschki D. Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. Am J Pathol. 2002 Sep; 161 (3) :947-56. PubMed PMID:12213723; PubMed Central PMCID: PMC1867252.
  2. Schindl M, Schoppmann SF, Samonigg H, Hausmaninger H, Kwasny W, Gnant M, Jakesz R, Kubista E, Birner P, Oberhuber G, Austrian Breast and Colorectal Cancer Study Group. Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer. Clin Cancer Res. 2002 Jun; 8 (6) :1831-7. PubMed PMID:12060624.
  3. Schoppmann SF, Horvat R, Birner P. Lymphatic vessels and lymphangiogenesis in female cancer: mechanisms, clinical impact and possible implications for anti-lymphangiogenic therapies (Review). Oncol Rep. 2002 May-Jun; 9 (3) :455-60. PubMed PMID:11956609.

2001

  1. Kriehuber E, Breiteneder-Geleff S, Groeger M, Soleiman A, Schoppmann SF, Stingl G, Kerjaschki D, Maurer D. Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages. J Exp Med. 2001 Sep 17; 194 (6) :797-808. PubMed PMID:11560995; PubMed Central PMCID: PMC2195953.
  2. Schoppmann SF, Schindl M, Breiteneder-Geleff S, Soleima A, Breitenecker G, Karner B, Birner P. Inflammatory stromal reaction correlates with lymphatic microvessel density in early-stage cervival cancer. Anticancer Res. 2001 Sep-Oct; 21 (5) :3419-23. PubMed PMID:11848503.
  3. Schindl M, Oberhuber G, Obermair A, Schoppmann SF, Karner B, Birner P. Overexpression of Id-1 protein is a marker for unfavorable prognosis in early-stage cervical cancer. Cancer Res. 2001 Aug 1; 61 (15) :5703-6. PubMed PMID:11479201.
  4. Schoppmann SF, Birner P, Studer P, Breiteneder-Geleff S. Lymphatic microvessel density and lymphovascular invasion assessed by anti-podoplanin immunostaining in human breast cancer. Anticancer Res. 2001 Jul-Aug; 21 (4A) :2351-5. PubMed PMID:11724292.

2000

  1. Schoppmann S, Pohlmann M. [Reflections on phenomenological research in nursing]. Pflege. 2000 Dec; 13 (6) :361-6. PubMed PMID:11221204.

Wissenschaftliche Reviews (invited):

  1. S.F. Schoppmann(correspondence), R. Horvat, P. Birner: “Lymphatic vessels and lymphangiogenesis in female cancer: Mechanisms, clinical impact and possible implications for anti-lymphangiogenic therapies (Review)” Oncol. Rep. 2002 May-Jun;9(3):455-60. IF: 1.5
  2. S.F. Schoppmann: “Lymphangiogenesis, Inflammation and Metastasis” invited review Anticancer Res 25: 2005 Nov-Dec;25(6C):4503-11. IF: 1.395
  3. S.F. Schoppmann(correspondence), Alexandra Fenzl, Friedrich Längle: ”Surgical oncology: impact of lymphangiogenesis for metastasis formation” Eur Surg. (2005) 37/3: 153-158. IF: 0.3
  4. S.F. Schoppmann, R. Jakesz: “Early-Stage Breast Cancer-Highlights at ASCO 2006” Breast Care 2006;1:. IF: 0.5
  5. M Gnant, P Dubsky, F Fitzal, P Blaha, S.F. Schoppmann, G Steger, C Marth, H Samonigg, K Hüttner, H Fohler, E Ruecklinger, R Jakesz, R Greil; Austrian Breast and Colorectal Cancer Study Group. Clin Breast Cancer. 2009 Jun;9 Suppl 1:S18-27. IF: 2.4
  6. S.F. Schoppmann, E Bareck, F Längle, J Zacherl: „ Gastrointestinale Stromatumoren“. Gastroenterologische und hepatologische Erkrankungen, 2009; 1(4), 45-52.
  7. P. Blaha, R. Exner, A. Dal Borgo, S. Biegenzahn, P. Panhofer, O. Riedl, S.F. Schoppmann, T. Bachleitner, E. Sporn, R. Jakesz, M. Gnant: „Is Endocrine Therapy Really Pleasant? Considerations about the Long-Term Use of Antihomonal Therapy and ist Benefits/Side Effect Ratio. Breast Care 2009, 4: 155-161 IF: 0.5

Buchbeiträge (invited)

  1. S.F. Schoppmann, M. Schindl, P. Birner: „The role of lymphatic vessels in gynecological cancer“ In: R.M. Mohan (Ed.): „Research Advances in Cancer“ Global Research Network, Kerala, 2/2002, 17-23.
  2. S.F. Schoppmann, D. Kandioler, R. Horvat: “Operative Verfahren beim DCIS” Springer-Verlag 2007
  3. S.F. Schoppmann: „Therapiemanagement von Lebermetastasen Gastrointestinaler Tumoren“, MUW-Univerlag 2007
  4. S.F. Schoppmann and Raimund Jakesz:“ Endocrine Therapy and breast cancer – the ABCSG story“ Breast Surgical Oncology British Surgery Text book
  5. S.F Schoppmann:“ Minimally invasive resections of diverticula of the esophagus“. Textbook and Atlas of Minimally Invasive Surgery, Rolpf Inderbitzi, Springer Verlag

Dissertation:

S.F. Schoppmann “Lymphatic Microvessels in Invasive Breast Tumors A Prognostic Factor?” Dissertation eingereicht Oktober 2000, 1. Begutachter: Prof. D. Kerjaschki, 2. Begutachter: Doz. G. Krupitza, Betreuerin: Prof. S. Geleff.

Eingebrachte Drittmittel

  • Hans-Blanca Moser Stiftung
    „Lymphangiogenesis and lymphovascular invasion in liver metastasis of colorectal cancer“ (A. Fenzl)
  • Jubiläumsfond der Österreichischen Nationalbank 2006
    „Vorhersage des Ansprechens auf anti-angiogenetische Tumortherapie“ Projektnummer 12072. Bewilligungsdatum 29.06.2006. Projektleiter: Dr. Sebastian Schoppmann,
  • Vergleisstudie MediGus Ltd
    Safety and Efficacy of the Medigus SRS Endoscopic Stapling System in Gastroesophageal Reflux Disease (GERD). Principal investigator NCT00734747
  • Unrestricted Reseach Grant (Fa. Novartis)
    Establishment of a tumor-database of Gastrointestinal Stromal Tumors (GIST)
  • Unrestricted Research Grant (Fa. Roche)
    Effect of Her-2/neu on lymphangiogenesis in gastroesophageal cancer.
  • Unrestricted Research Grant (Fa. Pejcl)
    Establishment of a new esophageal stent-system.
  • Unrestricted Research Grant (Fa. Pfizer)
    Erweiterung der GISt Datenbank Summe
  • Unrestricted Research Grant (Fa. Roche)
    Prospektive Evaluation der Her-2 expression in Biopsien von Magen und Ösophaguskarzinomen